Products Categories
CAS No.: | 2577-32-4 |
---|---|
Name: | Sulfapiridazin sodium |
Molecular Structure: | |
Formula: | C11H12 N4 O3 S . Na |
Molecular Weight: | 302.29 |
Synonyms: | Benzenesulfonamide,4-amino-N-(6-methoxy-3-pyridazinyl)-, monosodium salt (9CI); Sodium,[N1-(6-methoxy-3-pyridazinyl)sulfanilamido]- (7CI); Sulfanilamide,N1-(6-methoxy-3-pyridazinyl)-, monosodium salt (8CI);3-Methoxy-6-sulfanilamidopyridazine sodium salt; Sodium sulfamethoxypyridazine;Sodium sulfapyridazine; Sulfamethoxypyridazine sodium salt; Sulfapiridazinsodium; Sulfapyridazine sodium; Sulfapyridazine sodium salt; Sulfoxine LA |
EINECS: | 219-928-4 |
Density: | g/cm3 |
Boiling Point: | 564.9 °C at 760 mmHg |
Flash Point: | 295.4 °C |
Appearance: | white or yellowish crystal, odorless, bitter, its color will change when exposed to light. soluble in water, aqueous solution is basic, PH10~11. |
PSA: | 106.79000 |
LogP: | 2.38900 |
What can I do for you?
Get Best Price
Molecular Structure:
Molecular Formula: C11H12N4NaO3S
Molecular Weight: 303.2922
IUPAC Name: Sodium 4-amino-N-(6-methoxypyridazin-3-yl)benzenesulfonamide
Synonyms of Sulfapiridazin sodium (CAS NO.2577-32-4): Sulfamethoxypyridazine sodium salt ; EINECS 219-928-4 ; Sale sodico della 2-p-aminobenzensulfonamido-6-metossipiridazina ; Sale sodico della 2-p-aminobenzensulfonamido-6-metossipiridazina [Italian] ; Sodium sulfamethoxypyridazine ; Sodium sulfapyridazine ; Sodium, (N(sup 1)-(6-methoxy-3-pyridazinyl)sulfanilamido)- ; Sulfamethoxypyridazin natrium ; Sulfamethoxypyridazine sodium ; Sulfapyridazine sodium ; Benzenesulfonamide, 4-amino-N-(6-methoxy-3-pyridazinyl)-, monosodium salt (9CI) ; Sodium N-(6-methoxypyridazin-3-yl)sulphanilamidate
CAS NO: 2577-32-4
Product Categories: Drug / Therapeutic Agent
Flash Point: 295.4 °C
Enthalpy of Vaporization: 84.86 kJ/mol
Boiling Point: 564.9 °C at 760 mmHg
Vapour Pressure of Sulfapiridazin sodium (CAS NO.2577-32-4): 8.8E-13 mmHg at 25°C
Sulfapiridazin sodium (CAS NO.2577-32-4) is used for anti-infection medicine.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intravenous | 836mg/kg (836mg/kg) | Minerva Medica. Vol. 52, Pg. 1789, 1961. | |
mouse | LD50 | oral | 1120mg/kg (1120mg/kg) | Minerva Medica. Vol. 52, Pg. 1789, 1961. | |
mouse | LD50 | subcutaneous | 1087mg/kg (1087mg/kg) | Minerva Medica. Vol. 52, Pg. 1789, 1961. | |
rat | LD50 | subcutaneous | 1010mg/kg (1010mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 9, Pg. 286, 1959. |